T 46 (Clorazepate 7.5 mg)
Pill imprint T 46 has been identified as Clorazepate dipotassium 7.5 mg.
Clorazepate is used in the treatment of anxiety; alcohol withdrawal; seizure prevention and belongs to the drug class benzodiazepines. FDA has not classified the drug for risk during pregnancy. Clorazepate 7.5 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- T 46
- Strength:
- 7.5 mg
- Color:
- Orange
- Size:
- 9.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Benzodiazepines
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- 4 - Some potential for abuse
- Manufacturer:
- Taro Pharmaceuticals U.S.A., Inc.
- National Drug Code (NDC):
- 51672-4043
- Inactive Ingredients:
- silicon dioxide
magnesium stearate
microcrystalline cellulose
potassium chloride
magnesium silicate
D&C Red No. 6
aluminum oxide
D&C Yellow No. 10
| NDC Code | Manufacturer / Repackager |
|---|---|
| 67544-0579 | Prepak Systems Inc (repackager) |
| 68258-7012 | Dispensing Solutions Inc. (repackager) |
Note: Inactive ingredients may vary.
More about clorazepate
Consumer resources
- Other brands: Tranxene, Tranxene T-Tab, Tranxene SD
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
